Mylan says EpiPen manufacturing partner to expand device recall

(Reuters) – Generic drugmaker Mylan NV said on Friday that its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets. The announcement comes a week after Mylan said it had recalled about 81,000 EpiPen devices in countries outside the United States following two reports of the company’s allergy treatment failing to work in emergencies. The recall is being initiated in the United States and will extend to Europe, Asia, North and South America, Mylan said.